Pr Stéphane Oudard
- Specialty
- Oncologist, urology expert
- Title
- Head of service
- Hospital
- Hôpital Européen Georges Pompidou (Paris)
- Latest articles
-
- Exposure-response relationship of nivolumab and ipilimumab in patients with metastatic renal cell carcinoma from the randomised phase 2 BIONIKK study. (Feb 6, 2026)
- Feasibility of standard versus fractionated carboplatin-paclitaxel in older adults with ovarian cancer: a retrospective study. (Feb 1, 2026)
- Correction: Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care. (Feb 1, 2026)
- Real-World Outcomes of First-Line Immune-Based Combination Therapies in Bone-Metastatic Clear Cell Renal Cell Carcinoma. (Jan 14, 2026)
- Nivolumab in Metastatic Clear-cell Renal Cell Carcinoma: An Integrative Biomarker Analysis from the NIVOREN GETUG-AFU 26 Phase 2 Study. (Nov 11, 2025)